The FDA approved an updated label for Vabysmo for the treatment of macular edema following retinal vein occlusion beyond 6 ...

The FDA’s decision to extend the labeled duration of faricimab use in RVO beyond 6 months primarily reflects accumulated evidence supporting its continued efficacy and safety over longer treatment ...

Please provide your email address to receive an email when new articles are posted on . WAIKOLOA, Hawaii — In this expert perspective from Retina 2026, Sharon Fekrat, MD, FACS, FASRS, discusses a real ...

GameSpot may get a commission from retail offers. Code Vein 2 features three different endings, but unlike many similar games, they don't require you to enter New Game Plus to access them. Instead, ...

Pakistan Tehreek-e-Insaf (PTI) has raised serious concerns over former Prime Minister Imran Khan’s health, claiming his condition is in grave danger. The party has urged authorities to allow immediate ...

What Is Eylea HD, and Why Does It Matter? Eylea HD (aflibercept) is an injectable medicine used to treat certain eye conditions that can lead to vision loss. It works by blocking a protein called VEGF ...

On Wednesday, the U.S. Food and Drug Administration (FDA) approved Regeneron Pharmaceuticals Inc.’s (NASDAQ: REGN) Eylea HD (aflibercept) Injection 8 mg for patients with macular edema following ...

Retinal vein occlusion (RVO) is one of the leading causes of vision loss worldwide, often triggered by chronic diseases such as hypertension and diabetes. Similar to a blocked water pipe causing ...

A wireless retinal implant can restore central vision in patients with advanced age-related macular degeneration (AMD), according to clinical trial results published in the New England Journal of ...

Varicose veins are swollen, twisted veins caused by weakened valves that allow blood to pool. While often a cosmetic issue, they can pose health risks like blood clots and skin ulcers. Self-care ...

A retinal implant has partly restored vision in blind mice, suggesting it could one day benefit people with conditions such as age-related macular degeneration, which involves a progressive loss of ...

If approved, EYLEA HD would be the first and only treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period – halving the number of injections that are indicated ...